Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival?

Holub K, Conill C.

Clin Transl Oncol. 2019 Apr 19. doi: 10.1007/s12094-019-02113-y. [Epub ahead of print]

PMID:
31004253
2.

Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).

Maurel J, Sánchez-Cabús S, Laquente B, Gaba L, Visa L, Fabregat J, Povés I, Roselló S, Díaz-Beveridge R, Martín-Richard M, Rodriguez J, Sabater L, Conill C, Cambray M, Reig A, Ayuso JR, Valls C, Ferrández A, Bombí JA, Ginés A, García-Albéniz X, Fernández-Cruz L.

Cancer Chemother Pharmacol. 2018 Dec;82(6):935-943. doi: 10.1007/s00280-018-3682-9. Epub 2018 Sep 17.

PMID:
30225601
3.

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.

Carrera C, Gual A, Díaz A, Puig-Butillé JA, Noguès S, Vilalta A, Conill C, Rull R, Vilana R, Arguis P, Vidal-Sicart S, Alós L, Palou J, Castel T, Malvehy J, Puig S.

Melanoma Res. 2017 Aug;27(4):315-320. doi: 10.1097/CMR.0000000000000340.

PMID:
28296711
4.

Genomic analysis and clinical management of adolescent cutaneous melanoma.

Rabbie R, Rashid M, Arance AM, Sánchez M, Tell-Marti G, Potrony M, Conill C, van Doorn R, Dentro S, Gruis NA, Corrie P, Iyer V, Robles-Espinoza CD, Puig-Butille JA, Puig S, Adams DJ.

Pigment Cell Melanoma Res. 2017 May;30(3):307-316. doi: 10.1111/pcmr.12574. Epub 2017 Apr 19.

5.

In Regard to Kubicek et al.

Vargas A, Conill C.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):921-922. doi: 10.1016/j.ijrobp.2016.07.023. No abstract available.

PMID:
27788966
6.

[Solitary brain lesion in patients with cancer].

Vargas A, Aya F, Capurro S, Conill C, Verger E.

Rev Neurol. 2016 Aug 16;63(4):190. Spanish. No abstract available.

7.

Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study.

Podlipnik S, Carrera C, Sánchez M, Arguis P, Olondo ML, Vilana R, Rull R, Vidal-Sicart S, Vilalta A, Conill C, Malvehy J, Puig S.

J Am Acad Dermatol. 2016 Sep;75(3):516-524. doi: 10.1016/j.jaad.2016.02.1229. Epub 2016 May 13.

PMID:
27183845
8.

Spanish Multidisciplinary Melanoma Group (GEM) guidelines for the management of patients with advanced melanoma.

Berrocal A, Espinosa E, Marín S, Malvehy J, Moreno D, Lozano MD, Martin-Algarra S, Lopez JA, Conill C, Rodriguez-Peralto JL.

Eur J Dermatol. 2015 Sep-Oct;25(5):392-403. doi: 10.1684/ejd.2015.2594. Review.

PMID:
26693633
9.

Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.

García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J.

World J Gastroenterol. 2014 Nov 14;20(42):15820-9. doi: 10.3748/wjg.v20.i42.15820.

10.

A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) study.

Aparicio J, García-Mora C, Martín M, Petriz ML, Feliu J, Sánchez-Santos ME, Ayuso JR, Fuster D, Conill C, Maurel J.

PLoS One. 2014 Jan 9;9(1):e82209. doi: 10.1371/journal.pone.0082209. eCollection 2014.

11.

CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer.

Molina V, Visa L, Conill C, Navarro S, Escudero JM, Auge JM, Filella X, Lopez-Boado MA, Ferrer J, Fernandez-Cruz L, Molina R.

Tumour Biol. 2012 Jun;33(3):799-807. doi: 10.1007/s13277-011-0297-8. Epub 2011 Dec 29.

PMID:
22203495
12.

Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer.

Pera M, Gallego R, Montagut C, Martín-Richard M, Iglesias M, Conill C, Reig A, Balagué C, Pétriz L, Momblan D, Bellmunt J, Maurel J.

Ann Oncol. 2012 Mar;23(3):664-70. doi: 10.1093/annonc/mdr291. Epub 2011 Jun 7.

PMID:
21652581
13.

Comparison of positron emission tomography (PET) and computed tomography (CT) for better target volume definition in radiation therapy planning.

Vila A, Sánchez-Reyes A, Conill C, Gispert JD, Trampal C, Láinez C, Vayreda J, Pedro A.

Clin Transl Oncol. 2010 May;12(5):367-73. doi: 10.1007/s12094-010-0518-4.

PMID:
20466621
14.

Whole abdominal radiotherapy in ovarian cancer.

Biete A, Valduvieco I, Rovirosa A, Farrús B, Casas F, Conill C.

Rep Pract Oncol Radiother. 2010 Mar 23;15(2):27-30. doi: 10.1016/j.rpor.2010.02.004. eCollection 2010.

15.

[Changes in the incidence of falls in an intermediate and long-term care center].

Roqueta C, Vázquez O, de Jaime E, Sánchez C, Pastor M, Conill C, Catalán M, Miró M, Cervera AM, Miralles R.

Rev Esp Geriatr Gerontol. 2009 Nov-Dec;44(6):331-4. doi: 10.1016/j.regg.2009.07.005. Epub 2009 Oct 22. Spanish.

PMID:
19853323
16.

Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma.

Conill C, Valduvieco I, Domingo-Domènech J, Arguis P, Vidal-Sicart S, Vilalta A.

Clin Transl Oncol. 2009 Oct;11(10):688-93.

PMID:
19828412
17.

Prognostic value of tyrosinase reverse transcriptase PCR analysis in melanoma sentinel lymph nodes: long-term follow-up analysis.

González Cao M, Badenas C, Malvehy J, Martí R, Puig-Butille JA, Castel T, Rull R, Vilalta A, Vidal-Sicart S, Palou J, Vilella R, Conill C, Sánchez M, Walker G, Pons F, Puig S.

Clin Exp Dermatol. 2009 Dec;34(8):863-9. doi: 10.1111/j.1365-2230.2009.03210.x. Epub 2009 May 5.

PMID:
19438551
18.

[Quality of life and survival after surgical treatment of metastatic femoral fractures].

López VJ, Fernández-Valencia JA, Combalía A, Conill C, Ríos J.

Med Clin (Barc). 2009 Jul 4;133(5):177-9. doi: 10.1016/j.medcli.2008.11.030. Spanish.

PMID:
19307004
19.

Metastasis to the nasal cavity from primary rectal adenocarcinoma.

Conill C, Vargas M, Valduvieco I, Fernández PL, Cardesa A, Capurro S.

Clin Transl Oncol. 2009 Feb;11(2):117-9.

PMID:
19211379
20.

[Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].

Soriano-Izquierdo A, Adet AC, Gallego R, Miquel R, Castells A, Pellisé M, Nadal C, López-Boado MA, Piqué JM, Gascón P, Conill C, Bombí A, Fernández-Cruz L, Maurel J, Navarro S.

Med Clin (Barc). 2009 Feb 14;132(5):163-71. doi: 10.1016/j.medcli.2008.07.012. Epub 2009 Feb 7. Spanish.

PMID:
19211081
21.

Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients.

Ugidos L, Delgado S, Conill C, Ginés A, Gallego R, Ayuso JR, Miquel R, Tosca M, de Lacy A, Castells A, Maurel J.

Invest New Drugs. 2009 Jun;27(3):262-8. doi: 10.1007/s10637-008-9192-6. Epub 2008 Oct 16.

PMID:
18923810
22.

Brain nodules with lung mass: are they always metastases?

Jorcano S, Farrús B, Pujol T, Verger E, Marruecos J, Conill C.

Clin Transl Oncol. 2008 Aug;10(8):512-4.

PMID:
18667383
23.

Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.

Grau JJ, Caballero M, Monzó M, Muñoz-García C, Domingo-Domenech J, Navarro A, Conill C, Campayo M, Bombí JA.

J Surg Oncol. 2008 Aug 1;98(2):130-4. doi: 10.1002/jso.21096.

PMID:
18537153
24.

Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.

Conill C, Setoain X, Colomo L, Palacín A, Combalia-Aleu A, Pomés J, Marruecos J, Vargas M, Maurel J.

J Magn Reson Imaging. 2008 Mar;27(3):625-8. doi: 10.1002/jmri.21298.

PMID:
18307201
25.

Occipital condyle syndrome secondary to bone metastases from rectal cancer.

Marruecos J, Conill C, Valduvieco I, Vargas M, Berenguer J, Maurel J.

Clin Transl Oncol. 2008 Jan;10(1):58-60.

PMID:
18208794
26.

Prognostic implications of protein S-100beta serum levels in the clinical outcome of high-risk melanoma patients.

Domingo-Domènech J, Castel T, Auge JM, Garcia-Albeniz XA, Conill C, Puig S, Vilella R, Matas J, Malvehy J, Gascón P, Mellado B, Molina R.

Tumour Biol. 2007;28(5):264-72. Epub 2007 Oct 26.

PMID:
17962723
27.

Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases.

Conill C, Berenguer J, Vargas M, López-Soriano A, Valduvieco I, Marruecos J, Vilella R.

Clin Transl Oncol. 2007 Sep;9(9):590-5.

PMID:
17921107
28.

Toxicity of combined treatment of adjuvant irradiation and interferon alpha2b in high-risk melanoma patients.

Conill C, Jorcano S, Domingo-Domènech J, Marruecos J, Vilella R, Malvehy J, Puig S, Sánchez M, Gallego R, Castel T.

Melanoma Res. 2007 Oct;17(5):304-9.

PMID:
17885585
29.

Pathological femur fracture secondary to radiation therapy for soft tissue sarcoma.

Conill C, Tomás X, Combalia-Aleu A, Palacín A, Planas I, Maurel J.

Clin Transl Oncol. 2007 Aug;9(8):537-9.

PMID:
17720657
30.

Low dose rate brachytherapy in lip carcinoma.

Conill C, Verger E, Marruecos J, Vargas M, Biete A.

Clin Transl Oncol. 2007 Apr;9(4):251-4.

PMID:
17462978
31.

Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer.

Conill C, Marruecos J, Verger E, Berenguer J, Lomeña F, Domingo-Domènech J, Grau JJ, Casas F.

Clin Transl Oncol. 2007 Mar;9(3):172-6.

PMID:
17403628
32.

Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanoma.

Cao MG, Auge JM, Molina R, Martí R, Carrera C, Castel T, Vilella R, Conill C, Sánchez M, Malvehy J, Puig S.

Anticancer Res. 2007 Jan-Feb;27(1B):595-9.

33.

Clinical outcome after surgical resection of lung metastases from melanoma.

Conill C, Gimferrer JM, Marruecos J, Domingo-Domènech J, Vilella R, Catalán M, Malvehy J, Puig S, Castel T.

Clin Transl Oncol. 2007 Jan;9(1):48-52. Review.

PMID:
17272230
34.

Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer.

Maurel J, Martin-Richard M, Conill C, Sánchez M, Petriz L, Ginès A, Miquel R, Gallego R, Cajal R, Ayuso C, Navarro S, Marmol M, Nadal C, Augé JM, Fernández-Cruz L, Gascón P.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1391-8. Epub 2006 Sep 11.

PMID:
16965868
35.

Results of radiotherapy in primary cutaneous lymphoma.

Conill C, Navalpotro B, López I, Estrach T.

Clin Transl Oncol. 2006 Jun;8(6):430-4.

PMID:
16790396
36.

Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases.

Conill C, Jorcano S, Domingo-Doménech J, Gallego R, Malvehy J, Puig S, Sánchez M, Vilella R, Castel T.

Clin Transl Oncol. 2006 Apr;8(4):266-70.

PMID:
16648102
37.

Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma.

González Cao M, Malvehy J, Martí R, Conill C, Sánchez M, Martín M, Carrera C, Herrero J, Gascón P, Mellado B, Castel T, Puig S.

Melanoma Res. 2006 Feb;16(1):59-64.

PMID:
16432457
38.

[Radiation therapy in simultaneous choroidal and brain metastases].

Conill C, Jorcano S, Planas I, Marruecos J, Casas F, Fontenla JR.

An Med Interna. 2005 Sep;22(9):431-3. Spanish.

PMID:
16386076
39.

[Cost and value of radiation therapy].

Conill C, Peiró M, Bisbe J.

Med Clin (Barc). 2005 Oct 22;125(14):557-8. Spanish. No abstract available.

PMID:
16266643
40.

Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial.

González Cao M, Puig S, Malvehy J, Herrero JE, Martí RM, Conill C, Sánchez M, Mellado B, Gascón P, Castel T.

Clin Transl Oncol. 2005 Jul;7(6):250-4.

PMID:
16131448
41.

Malignant melanoma with metastasis into the capitate.

Tomas X, Conill C, Combalia A, Pomes J, Castel T, Nicolau C.

Eur J Radiol. 2005 Dec;56(3):362-4. Epub 2005 Aug 24.

PMID:
16125354
42.

Use of ear tags and injectable transponders for the identification and traceability of pigs from birth to the end of the slaughter line.

Caja G, Hernández-Jover M, Conill C, Garín D, Alabern X, Farriol B, Ghirardi J.

J Anim Sci. 2005 Sep;83(9):2215-24.

PMID:
16100077
43.

Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCR.

Domingo-Domènech J, Molina R, Castel T, Montagut C, Puig S, Conill C, Martí R, Vera M, Auge JM, Malvehy J, Grau JJ, Gascon P, Mellado B.

Oncology. 2005;68(4-6):341-9. Epub 2005 Jul 11.

PMID:
16020961
44.

Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.

Maurel J, Cervantes A, Conill C, Salazar R, Martin-Richard M, Pera M, Manzano H, Chirivella I, Gallego R, Marfa X.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):91-6.

PMID:
15850907
45.

[Radiation leukoencephalopathy. Clinical and radiological evolution].

Conill C, Jorcano S, Pujol T, Malvehy J.

Med Clin (Barc). 2004 Oct 2;123(11):437. Spanish. No abstract available.

PMID:
15482724
46.

Secondary orbital metastases from cutaneous melanoma.

Conill C, Morilla I, Malvehy J, Toscas I, Puig S, Pujol T.

Melanoma Res. 2004 Oct;14(5):437-8. No abstract available.

PMID:
15457105
47.

Intramedullary spinal cord metastases of melanoma.

Conill C, Sánchez M, Puig S, Planas I, Castel T.

Melanoma Res. 2004 Oct;14(5):431-3.

PMID:
15457103
48.

Angiolymphoid hyperplasia with eosinophilia of the nail bed and bone: successful treatment with radiation therapy.

Conill C, Toscas I, Mascaró JM Jr, Vilalta A, Mascaró JM.

J Eur Acad Dermatol Venereol. 2004 Sep;18(5):584-5.

PMID:
15324400
49.

Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients.

Cuéllar FA, Vilalta A, Rull R, Vidal-Sicart S, Palou J, Ventura PJ, Pous E, Quinto L, Malvehy J, Martí R, Puig S, Vilella R, Soler J, Benítez D, Yachi E, Lecha M, Pons F, Conill C, Visa J, Castel T; Malignant Melanoma Group.

Melanoma Res. 2004 Aug;14(4):277-82.

PMID:
15305158
50.

Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid.

Conill C, Sánchez-Reyes A, Molla M, Vilalta A.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1326-9.

PMID:
15275716

Supplemental Content

Loading ...
Support Center